Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Li Zhong Xiao Pi Granules in Diabetic Gastroparesis (Phase II)
CTR20240777Phase 2Active
- Sponsor
- Beijing Yingkerei Pharmaceutical Technology
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lizhong Xiaopi Granules in diabetic gastroparesis, sponsored by Beijing Yingkerei Pharmaceutical Technology. Started Mar 2024; status: active.
02
Drugs
Lizhong Xiaopi Granules
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on CTR20240777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240777.